Skip to main content

Table 1 Dietary intake, body weight and various organ weights

From: Anti-diabetic effect of sorghum extract on hepatic gluconeogenesis of streptozotocin-induced diabetic rats

 

NC

DM

DM-SE 0.4

DM-SE 0.6

DM-G

Dietary intake (g/day)

22.10±0.23a

25.94±1.30b

26.65±1.60b

28.41±1.26b

27.11±1.27b

Initial body weight (g/day)

246.20±6.76a

208.60±7.79b

213.20±7.36b

206.60±9.27b

207.80±14.15b

Final body weight (g/day)

491.40±9.01a

375.40±43.17b

347.60±35.94b

385.40±30.44b

323.40±38.45b

Liver (mg/g body weight)

11.52±0.57a

11.40±0.66b

12.27±0.63b

12.04±0.30b

10.83±0.69b

kidney (mg/g body weight)

2.73±0.10a

2.91±0.07b

2.65±0.08b

2.72±0.06b

2.83±0.11b

Retroperitoneal fat (g)

12.11±1.07a

8.52±0.62b

8.32±1.60b

8.99±0.56b

6.78±0.34b

Epididymal fat (g)

11.82±0.81a

8.97±0.27b

6.73±1.44b

8.68±0.35b

6.40±1.27b

Perirenal fat (g)

0.99±0.21

0.93±0.15

0.94±0.15

0.75±0.15

0.84±016

  1. Values are expressed as the mean ± SEM (n = 5); NC, normal control rats administrated saline; DM, rats with diabetes mellitus administrated saline; DM-SE 0.4, rats with diabetes mellitus administrated 0.4 g/kg body weight of sorghum extract; DM-SE 0.6, rats with diabetes mellitus administrated 0.6 g/kg body weight of sorghum extract; DM-G, rats with diabetes mellitus administrated 0.7 mg/kg body weight of glibenclamide. The values in the rows with different letters are significantly different at p < 0.05 using ANOVA with Duncan’s multiple range test.